Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3

CompletedOBSERVATIONAL

Enrollment

15,330

Participants

Timeline

Start Date

October 21, 2014

Primary Completion Date

July 14, 2020

Study Completion Date

July 14, 2020

Conditions

Hyperlipidemia

Interventions

DRUG

Omega-3 fatty acid ethyl esters

Omega-3 fatty acid ethyl esters granular capsules

DRUG

Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).

Trial Locations (2)

Osaka

Tokyo